Latest Post

Summary : -The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order to reduce the development time required for drug …

Summary : AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria. The results from the trial immunogenicity and safety trial, D7220C00001, reveal …

Summary : -Recent Publications by Several Independent Laboratories Show ADG20 Has Neutralizing Activity with Potency Comparable to Other Antibodies that Retain Activity Against Omicron -Multiple Efforts Underway to Address Omicron …

Summary :  The new networking platform is designed to meet the increasing need for the connection and support required to nurture the entrepreneurial and small business communities in Hong Kong …

Summary : Marksans Pharma Limited (Reuters: MARK.BO; Bloomberg: MRKS IN; NSE: MARKSANS; BSE: 524404) has received final approval from US Food & Drugs Administration for its Abbreviated New Drug Application …

 Summary : The international systems for trademark and design protection continues to grow with Jamaica the latest country to file instruments of accession. The more countries that join the systems …

 Highlights – Presbyopia, or age-related blurry near vision, is a common, progressive condition that reduces the eye’s ability to focus on near objects and affects nearly half of the U.S. …

Synopsis: EMA has started evaluating an application for a conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 and ritonavir). The applicant is Pfizer Europe MA EEIG. The application …

Summary : Anupam Rasayan India, a custom synthesis & speciality chemical firm, has signed a letter of intent (LoI) worth $95 million (i.e. Rs 700 crore) with a major multinational …

Synopsis: -By 2025, the company aims to generate $60 billion in pharma sales, leaning mostly on existing medicines for growth until then, new CEO Joaquin Duato said during the virtual …

Synopsis: The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented. Cancer researchers at the University of …

Summary : -The National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination (FAD) recommending Rinvoq (upadacitinib) 15mg as a new option for treating adults with …

Synopsis : TARZED is considered safe and more efficacious compared to conventional treatment medicines for breast cancer. Cadila Pharmaceuticals Limited on Wednesday announced that it has launched Trastuzumab, with the …

Summary : -Nordic Nanovector ASA (OSE: NANOV) provides an update on the timeline for PARADIGME, its ongoing pivotal Phase 2b trial of Betalutin® (177Lu lilotomab satetraxetan) in 3rd-line relapsed rituximab/anti-CD20 refractory follicular …

Summary : Rigel Pharmaceuticals, Inc. Inducement Plan, as amended, with a grant date of January 6, 2022, as an inducement material to the new employees entering into employment with Rigel, …

Summary : -Maharashtra health minister Rajesh Tope has inaugurated Bharat Serums and Vaccines (BSV)’s research and development centre at Airoli. -BSV, a leading biopharmaceutical company in India reaffirmed its commitment …

Synopsis: The State of Haryana has seen the highest number of new companies manufacturing ayurvedic medicines registered during the fiscal year 2020-21, with almost 40 per cent of the total …

Synopsis: Neurimmune AG, a biopharmaceutical company, announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca’s Rare Disease group, to develop NI006, an investigational …

Indomethacin is shown to be highly efficient in treating the Covid infection as per a study conducted by Dr Rajan Ravichandran, director nephrology, MIOT Hospitals and Prof R Krishna Kumar, …

Synopsis: Jubilant Therapeutics Inc, a biopharmaceutical company, announced US Food and Drug Administration (FDA) clearance of the investigational new drug application (IND) for JBI-802, a novel, oral, potent and selective …

Synopsis : This strain of the SARS-CoV-2 carries the N501Y mutation While the world is pulling in resources to fight back against the Omicron variant of the coronavirus, scientists have …

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm is investigating potential claims against LifeStance Health Group, Inc. (NASDAQ: LFST), Lockheed Martin Corporation (NYSE: LMT), CareDx, Inc. …

Highlights : Collaborative efforts aim to accelerate drug discovery and improve clinical success Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine platform from target identification through patient selection Research …

Synopsis: The objective of the issue is to meet the company’s financing needs for repayment of subordinated debt due, financing research and development initiatives and general corporate purposes, among others, …

MINUTES OF THE 435th REGISTRATION COMMITTEE MEETING HELD ON 23.12.2021. The 435th meeting of the Registration Committee (RC) was held under the Chairmanship of Dr. K. Malhotra, Chairman, Registration Committee …

Summary : AstraZeneca has completed the transfer of its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/formoterol) to Covis Pharma Group (Covis …

Summary : -Abbott, a global healthcare leader, announced that the US Food and Drug Administration (FDA) has approved new expanded magnetic resonance imaging (MRI) compatibility for its Proclaim XR Spinal …

Summary : Clover Biopharmaceuticals, Ltd. (Clover; Stock Code: 2197.HK), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates and Ascentage Pharma (6855.HK), a globally focused biopharmaceutical company …

Summary: -Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today confirms the previously communicated timelines of its clinical trials and regulatory submissions for its inactivated, adjuvanted COVID-19 …

Summary : -Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) today announced that wholly owned subsidiary Mitsui Chemicals Agro, Inc. (Tokyo; President & CEO: OZAWA Satoshi) has completed …

Summary – -The Indian Institute of Science (IISc) department of Microbiology and Cell Biology (MCB) and the Centre for Infectious Disease Research (CIDR) researchers and their  collaborators from the Bangalore …

Synopsis -Ahead of its New Year’s Day decision deadline at the FDA, Xeris Biopharma has snagged an approval for Recorlev, a drug formerly known as levoketoconazole. Based on results from …

Synopsis : -Novo Holdings acquired South Carolina-based sterile injectables manufacturer Ritedose for an undisclosed price. Ritedose, which specializes in blow-fill-seal technology and has been focusing on the outsourced sterile compounding …

Summary : Sperogenix will receive exclusive rights for development and commercialization of vamorolone for the treatment of Duchenne muscular dystrophy (DMD) and any other rare disease Santhera to receive a double-digit upfront cash payment plus short-term US-regulatory milestones amounting to USD 20 million combined, in a deal valued …

Synopsis: -Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) issued its decision upholding the validity of US Patent No. 9,187,405 covering a dosing regimen for …

Summary: ALLN-346, an orally administered enzyme in development for the treatment of hyperuricemia and gout, demonstrates a statistically significant reduction in serum uric acid and a well-tolerated safety profile in …

Synopsis: Bharat Biotech on Monday informed that India has supplied another batch of humanitarian assistance consisting of 5,00,000 doses of COVID-19 vaccine, Covaxin to Afghanistan. Bharat Biotech on Monday informed …

Summary ; -Oncoheroes will fund and advance the clinical development of both dovitinib and stenoparib in pediatric cancers, utilizing Allarity’s DRP® companion diagnostics -Allarity has submitted a new drug application …

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Todos Medical President & CEO Gerald Commissiong will be presenting at the upcoming Emerging …

Summary : Received the CES 2022 Innovation Awards in Health and Wellness following a CES 2018 Best of Innovation Award in VR/AR Looxid Labs Inc., a Virtual Reality(VR)-based proactive mental …

Synopsis; – The Drugs Technical Advisory Board (DTAB) has recommended introduction of barcode or QR code in the top 300 brands of drug products available in the Indian market to …

Summary : –  Growing body of evidence validates Vir’s approach of targeting a highly conserved region of the spike protein – Together with recent pseudo- and live virus results, additional …

Bioretec Ltd a globally operating Finnish medical device company, announced that the company has submitted an application for the CE mark for the first product in its new RemeOs product …

Blueprint Medicines Corporation  a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on December 1, 2021, the Compensation Committee of Blueprint …

Summary : – Expands Blueprint Medicines’ lung cancer pipeline with LNG-451, a highly selective brain-penetrant precision therapy targeting EGFR exon 20 insertion mutations – Investigational New Drug application for LNG-451 …

Summary : Granules India on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed salts indicated for the treatment of Attention Deficit Hyperactivity …

Summary : -Biocon Biologics Ltd, said its partner Viatris has won favourable decisions from a US federal court in Sanofi’s challenge over unpatentability of device patents for disposable insulin injection …

Summary : Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapies, today announced the closing of the collaboration agreement with AstraZeneca to develop and commercialize eplontersen, Ionis’ investigational antisense …

Highlights: -Visiongain has published a new report on Antimicrobial Hospital Curtains Market Report to 2031. Market is segmented by type (Reusable antimicrobial hospital curtains, Disposable antimicrobial hospital curtains), BY Material …

Highlights: Screened approximately 700 subjects and expanding to Eastern Europe, including Turkey, as part of its clinical diversification plans to support global regulatory approvals No serious adverse events and safety …